Abstract:
Isolated nucleic acids encoding an anti-IL-12 antibody or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders.
Abstract:
In one embodiment, the methods and apparatuses display a list configured to represent a plurality of virtual rooms; identify a selected participant device associated with a selected virtual room from the plurality of virtual rooms wherein the selected participant device is a member of the selected virtual room; selectively display content associated with the selected virtual room to the selected participant device; and notify the selected participant device of a change to the content associated with the selected virtual room.
Abstract:
Techniques are provided for tracking and analyzing defect density by source file or module. Defect density is the number of distinct defects which required changes to be made (to fix the defect) to a particular file or module in a given period of time. This metric is very useful for identifying the most critical areas of weakness of the system and hence the areas where additional investment/action may be taken. For example, this metric can be used to prioritize the area in which unit tests should be written, for which additional automated system tests should be written or which a project should be undertaken to re-write the error prone file or module to improve its quality and maintainability.
Abstract:
In one embodiment, the methods and systems detect a meeting; detect a missing participant scheduled to attend the meeting; identify a device actively utilized by the missing participant; and transmit a reminder message to the device.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract:
An apparatus and a method detect arc faults in an electrical power distribution system of a vehicle. In one implementation, the apparatus (320) includes: a load current input (340) arranged to obtain a measurement of current being supplied to a load (140) via a solid state power switching device (310) of the electrical power distribution system; and an arc fault detector (330) arranged to compare the measured load current with a load signature, the load signature being a function of characteristics of the load (140) being supplied current via the solid state power switching device (310) and operating conditions of the solid state power switching device (310). The arc fault detector (330) outputs an arc fault indication signal when the measured current is outside an allowable range of the load signature to provide protection against arc faults.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract:
The present invention relates to at least one novel anti-TNF antibodies, including isolated nucleic acids that encode at least one anti-TNF antibody, TNF, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.